. >> coming up, what do eli lilly and the indy 500 have in common? sullivan he'll join us live from the racetrack minutes from now with the key takeaways with his teieof eli lilly's ceo david ricks, that's next this is our future, ma. godaddy airo. creates a logo, website, even social posts... in minutes! -how? -a.i. (impressed) ay i like it! who wants to come see the future?! get your business online in minutes with godaddy airo (vo) what does it mean to be rich? get your business online in minutes maybe rich is less about reaching a magic number... and more about discovering magic. rich is being able to keep your loved ones close. and also send them away. rich is living life your way. and having someone who can help you get there. the key to being rich is knowing what counts. (ella) fashion moves fast. setting trends is our business. we need to scale with customer demand... in real time. (jen) so we partner with verizon. their solution for us? a private 5g network. (ella) we now get more control of production, efficiencies, and greater agility. (ma

but does news like this set them up, not to get a lilly valuation, but to take them from a 15 multiple, you know, maybe to the mid 20s, which would suggest the stock is ridiculously cheap here. >> great question. i think mid-20s seems super high lilly and novo really didn't get those multiples until they had proved to everybody that the drug was safe and effective and they can make it so, a lot of things had to happen right, and they did for those two. i don't think it will get to the mid 20s. could it creep up into the high teens just based on the hype and the euphoria going into the full phase two later this year, as people kind of take a bet on it? because it will be transformational, if it is great and very competitive they said tonight that they're working on manufacturing al already, so, maybe there is more upside here. i've been kind of net neutral, not net neutral, but -- the stock price, you know, when weer with on the last time, and i came on, talking about, you know, this stock relative to novo and lilly, didn't like as much it's basically right back to where it was so, ther

there for the last couple of years and lilly is just there, i think that could be the case where lillyld eat a little bit of novo's lunch, but lilly's chart looks much better. >> yeah, the trailing at 120 pe means nothing, because we know what's going on in terms of the eps growth. but back to that competitive landscape. competitors are not closing in as fast here. we know that just structurally in terms of the timeline. comparing this to nvidia, i think there's more competition there. >>> there's a lot more "fast money" to come. here's what's coming up next. >> ethereal ether. the crypto soaring as traders bet a new etf is on the horizon. what approval could mean for the whole digital coin space. we'll dig into the ethereum delirium next. >>> plus, lulu getting stretched, and not in a good way. shares hitting the mat, and trading at its lowest level in more than a year. does the drop present a good buying opportunity or should you nama-stay out of this snake? you're watching "fast money," live from the nasdaq market site in times square. we're back right after this. at corient, wealth

eli lilly up more than 300%. not as much for astrazeneca.although they did put up a good quarter of guidance, but over the last three years that stock underperforming. one area of potential growth in the future for these stocks be medicare advantage. right now it's not covered but the fda did approve will go ovi to improve the risk of heart attacks and stroke in overweight people and this could clear the path for approval from medicare for at least will go ovi and maybe the other loss drugs. take a look at the number of people this could bring to these drugs potentially in 2020 4 million people are expected to be enrolled in medicare advantage and the numbers only go in the right direction. let's take a look at those stocks in perspective once again here we have the s&p 500 and the health care index both higher over the last three years. take a look at eli lilly it is clearly the big winner, outperformance for some of these weight loss drugs. katie: that is a huge gap on the screen and feels like it's only getting bigger. for more on the wei

eli lilly, we just covered them.'s all summers form relation we should hear about very soon. this is not the dental, but it is the boyle company. so, we have oil, we have tech, because we know nvidia, obviously. united health, doesn't conflict with lilly? this is a drug insurer, and this is a health company, but they trade together in the health cohort, although, sometimes, when you trade on a hack, it is still different. what we are going to do is get rid of united health and i want to substitute a true industrial. the one i have my eye on is rtx, that was that merger with united states technologies. i have been working on it all weekend i think it is really good but getting away from it. that is what i suggest. next up, we have larry in oklahoma. larry? >> boo, yeah, jim. >> fired up, right? >> i think i have seen the movie "ted," too many times. >> that could be. >> here are my five stocks. >> microsoft, one strike, exxon, one oak, and apple. am i diversified? >> well, okay. now, we have to go back, microsoft is c

--- a big investment from eli lilly nonetheless. joining us is clear harbor asset management co. founder -- co founder and ceo. you take a look at the week that was, tech is the only sector in the green out of 11. what does that say about when we might see this rally broaden out? we have been waiting and waiting. >> it's interesting, katie, to your point about tech, it is the only sector in the last five days that is in the green, and the overall s&p 500 as an example is down 30, the five bases point over that same time. when you look at tech as representing one third of the overall market, we have a little bit of a window into that. the broadening question is an important one. the russell 2000 is not up 2% on a year-to-date basis even though the s&p is up almost 12%. there is sensitivity around the state of the consumer as it pertains to the domestic nature of smaller cap names, the broadening of that market is probably going to require more confident for the consumers in good shape. keep in mind the small-cap part of the market is

both of those, reasons why we're seeing e eli lilly up eli lilly up 3%. >>> ether, what it might mean the rest of the crypto space as well. tamra, izzy, and emma... no one puts more love into logistics than these three. you need them. they need a retirement plan. work with principal so we can help you with a plan that's right for your team. let our expertise round out yours. >>> coming up next, we're less than an hour away from toll brothers results. we'll run you all the key erme is to watch out forn ovti. that and much more as we take you inside the market zone next. this is our future, ma. godaddy airo. creates a logo, website, even social posts... in minutes! -how? -a.i. (impressed) ay i like it! who wants to come see the future?! get your business online in minutes with godaddy airo so this is pickleball? it's basically tennis for babies, but for adults. it should be called wiffle tennis. pickle! yeah, aw! whoo! ♪♪ these guys are intense. we got nothing to worry about. with e*trade from morgan stanley, we're ready for whatever gets served up. dude, you gotta work on your trash ta

eli lilly up about 3.2% on the day. quayside technology among the biggest laggards. the maker of measurement equipment issued a forecast that disappointed wall street. some analysts see green shoots emerging from its communications a business. quayside down almost 10%. earlier today, we have to know one of wall street's most prominent bearers, morgan stanley chief u.s. equity strategist mike wilson hiked his s&p target about day ago. he spoke about his outlook. >> are housecall, it is a soft landing goldilocks outcome. we are not that confident we want to make it fully. it is still late cycle, which means quality. large caps over small caps. we like staples over discretionary. we have two defensive sectors overweight utilities and stables because it protects against slowing growth risk. the main factor that has been working his quality. quality has been the most consistent factor and we don't see that changing. sonali: we will discuss the market now and outlooks with bloomberg's opinion columnist who watches it closely. interesting to see what was wall street's bigge

and it's a window which novo nordisk and eli lilly argue. look, we develop these drugs, we should make some money in that period. we should benefit. i agree with them, but i would argue they don't need to make quite as much as they currently do. we could regulate them. you know, at the moment, novo nordisk is now the most profitable company in, the whole of europe. so i think we should be, you know, prioritizing, getting the drugs to people who need them, not least because by many measures, obesity is the killer in this country. professor mander at harvard, who the food label that's on all food the united states sold in the us. so explain to me, presented with his calculations that obesity and food related illnesses. kill 678,000 american boys every year that's more all the american soldiers who died in all the wars of the 20th century and indeed the war in this century and. i mean, that is a staggering toll. that's, you know, not far off having covid every year. the covid pandemic, every year. right. and that stock, we shouldn't accept this

they don't want lilly. >> would you include lilly in a modern version of the mag seven? of that is because i respect ken langone so much. he was the first guy who said it was going to triple. you have to. dave ricks, again, you got these people, they just don't change dave ricks is the same guy, and the cfo is fantastic they are just busy trying to meet demand wherever they can. that's like, nose to the ground, let's make enough available for customers. and let's not have it so they have knockoffs the knockoffs will not have success. these are drugs that have to be refrigerated correctly you have to worry about the supply chain lilly has always said, listen, you got to be very careful but that stock is going to have a lot of staying power as one after another -- dr. gottlieb, scott gottlieb, who's on the board of pfizer, did say that he expects that they're like the statins. i remember when the first statins came out, and here we're talking about 1987 with merck, and people just said, well, you know, it will never catch on too expensive, whatever. and then, you know, a f

and it's a window which novo nordisk and eli lilly argue. look, we develop these drugs, we should make some money in that period. we should benefit. i agree with them, but i would argue they don't need to make quite as much as they currently do. we could regulate them. you know, at the moment, novo nordisk is now the most profitable company in, the whole of europe. so i think we should be, you know, prioritizing, getting the drugs to people who need them, not least because by many measures, obesity is the killer in this country. professor mander at harvard, who the food label that's on all food the united states sold in the us. so explain to me, presented with his calculations that obesity and food related illnesses. kill 678,000 american boys every year that's more all the american soldiers who died in all the wars of the 20th century and indeed the war in this century and. i mean, that is a staggering toll. that's, you know, not far off having covid every year. the covid pandemic, every year. right. and that stock, we shouldn't accept this

yours stands out as being one of the best >> wow >> caller: what can you tell me upcoming with lilly?the other day and they did a study how people feel about lilly very versus wegovy, zepbound versus novo nordisk lilly is so far and away a winner i say you've got toent stock. let's hope it comes in so you can buy more thank you for the kind words let's go to reese in illinois. reese. >> caller: boo-yah, jim. i'm talking about a tech conglomerate in the entertainment space that never gets talked about. it has glowing revenues in gaming, movies, music and hardware including sensors in the iphone it issued a buyback, dividend increase and a 5 to 1 stock split all while having a p/e of just 14 yet it's stuck in the mud. the stock i'm talking about is sony group stock ticker sony. >> they've got to get out of this, tell me listen, we're not interested in a takeover because i just like the stock as is and it's been weighed down by the takeover talk. and that, ladies and gentlemen, is the conclusion of the "lightning round"! the fuel you need to take flight. cirkul is the energy that gets yo

eli lilly has gotten a little extended. merck is trading at an all-time high. you get help from bristol myers at some point. and you have to love the space in general. >> it's interesting that you think eli lilly maybe from a valuation standpoint, guy, but really has been con sal dating over the last three months. we think about the guidance they just gave, and when you think about their glp-1 contribution to revenue growth, $18 billion on a $42 billion annual number or so, and it's still expected, total revenue base is growing 20% plus a year for the next couple years. so, again, if companies like roche are not going to have a real competitor for awhile, it seems like this is a very narrow trade, again, and sooner or later, another beat and raise and the stock is blowing out. it's going to have another gap higher. >> so, eli lilly and novo can protect that moat, because they have years before companies bring the product to market. but with the positive drug trial results, you get a reset. you get the markets thinking, they can be a contender that i are in the

let lilly come down and buy a bundle. >> jim, let's get the opening bell here.board, it is the consulate general of mexico in new york. cinco de mayo is this sunday. at the nasdaq, it's the committee to protect journalists. speak of amgen. that's going to be the lion's share of the dow. >>mgen is a great company, and bradway is a serious executive. they have an anti-cholesterol drug that's still not getting its due. they have a terrific migraine drug that is not getting its due. and all i can tell you is that they're a juggernaut that people don't think is a juggernaut, and their dow stock that everyone was unexcited about, but they and pfizer are the two drug stocks that are suddenly in the conversation again. and i think it's important to point out that pfizer may have some momentum too. >> yeah, huge weight in the dow, even before the jobs number was going to account for a couple hundred points of gain. >> sure, and obviously, the treasurys are signaling there's got to be s&p buying, and david, there were -- when we look at what happened with the megacaps, i

he hello, tom. >> janice: greatest two minutes of sports go. >> start with official drink, oaks lillye ounces of cranberry, ounsz of lemonade, boom, triple sec, orange liquor. i made your alcohol free. entertain responsibly. mine has the hooch. >> janice: what is next? so refreshing. >> start the morning with blazing saddle mary, bloody mary mix kicked up, here is the kick, it's garnish and maple bourbon bacon. we have pimento, and cheese and added bacon and toasted pecan, as sandwich, on crackers or as dip. cheers to great oaks day. >> janice: 150th kentucky derby. christine moore designed my hat. these drinks are not watered down. >> lawrence: get the recipes on "fox and friends."com. >> brian: u.s. added 175,000 jobs last month, less than predicted. s other stories, virginia man arrested in turks and caicos for having ammunition. his father said he is terrified and hanging in there, his life, his wife and their child and our lives have been overturned, he faces 12 years in prison. he left stray bullets in his luggage following a hunting trip. >> lawrence: this happened to me before

lilly, there's a bunch of surveys out.ple are talking about that there really is no substitute for their mounjaro or zepbound, and i've been using this outfit. jason alerted me to them it's an outfit called -- it's 100 x, which is a research outfit, and they have data which just shows that lilly is crushing it in terms of usage in ten. if people really want to use lilly over wegovy, and this idea of these compound hims and hers, those are not liked by people. when i check in with lilly, they are very, as always, nonpromotional, but they're going round the world, and i do believe ken langone is right, that that's going to be a trillion dollar company. >> to your point about pfizer, $1.5 billion in cost cuts by 2027, which they mentioned today. but jim, as for now, top five components are going to be nvidia, super micro, western dig, hp. >> the usual gang. super micro is a little less proprietary. hock tan is doing a very good job. we do have to do our show from a datacenter i think we have to wear cooling clothes. >> are yo

the trims of lilly, broadcom and wells? >> all performance based. two of these stocks are stocks up well north of 100% for us. in a very short order, we are still overweight in the stocks and it's right sizing the positions. wells is a little different. i am net interest margin pressures, and, you know, they are investing deeply in the wealth management business, which we think could pressure profitability so we reduced it a bit. >> do you not like the banks here? >> we like jp and wells. wells is one of our holdings, but just a trim. it has performed remarkably since we added it. comcast, the parent of this network actually -- this is a tax loss simply to offset -- >> for you, i bet you have a lemon in your throat right now. >> it's more like a cantaloupe that i have in my throat right now. anyway, we are taking tax losses for all the gains we are taking in the portfolio. >> you bought ibm and 3 m and deckers, all those, right? >> yeah, we made some real purchases here. deckers, uggs, not cheap, and trades at 27 times but it's two times the profita

>> we announced big partnerships with eli lilly and novartis. we are working on real drug programs.ould be expecting in the next couple of years the first ai designed drugs in the clinic. tom: that's really interesting. i know this is a passion of yours. you oversee this unit. it's a separate business under the bow -- alphabet family. you have those partnerships. novartis and eli lilly. up to $3 billion of revenue. does alpha fold three get you closer? >> yeah. it's a critical part of the tools we have at isomorphic. there's a lot of different techniques and modules that are needed in order to cover the whole of that very difficult process. alphafold2 is one small component of that. moving into things like biochemistry so we can design the right drug compounds. tom: are you under pressure to commercialize these products? what is the potential revenue stream of that? >> first and foremost, it's the most beneficial thing. the number one thing ai can do for humanity, solving hundreds of terrible diseases. i can't imagine a better use case for ai. that's partly the motivation behind iso

see large overweights relative to what you would find in a traditional index, like names like eli lillyvex. these are game-changing drugs, and the traditional means of getting into them, it doesn't do justice to the exposure needed >> i think it has been slow launching these considering they have been out for over a year. there are 20 companies in the eft, and i will not go through all of them, but 40% for two companies, and novo is up and lilly is up, and how much room is there we seem to be coming a little bit after the first crest? >> yeah, like when we saw the ai wave, and people said it's an ai bubble and it's over, and what is exciting is there's more companies coming, right? right now they are injectables, and there are companies working on oral therapeutics, and they are even more powerful >> we will talk about all of them coming up but you had a big hit last year, the big eft hit, mags, it came out of nowhere, and you will have a concentrated bet on china this time, and this consists of eight china, alibaba, jd.com -- why are you making a concentrated bet on china right now? i

these are the ways that novo nordisk and eli lilly are finding ways to pay for the drugs.iver disease and kidney disease. that is why these drugs have a popular future. >> amgen is doing the first human trials and expected to have results in june i want to talk about something else regulation you are shaking your head. in the u.s., regulators accusing novo nordisk and a bunch of other drugmakers, to be fair, for having fake patented that won't hold up to scrutiny. how much of a risk is this >> it is typical for the ftc to put out a list of fake patent. the patents are massive. many patents covering them i think this is really just a bit of non-news. >> non-news? doesn't it raise the risks of generics entering the market which would reduce price and take market share? >> when a drug gets approved, there are lots of patents. typical patents are 100 to 150 covering formulation and how it works. those are not being challenged here i don't think this brings a risk of generics. that will come in the 2030s. we need to watch out for the long term. that is why the pipeline is impor

. >> my five stocks are amazon, honeywell, amd, microsoft, eli lilly. am i diversified?od question. we will let amazon be cloud computing. honeywell diversified manufacturer that we own for travel trust. eli lilly is probably to me the number one drug company in the world. this is what's important. microsoft and amd. we will have to make a choice. we will have to say we want to keep microsoft. we will have to go with amd. what we will do is why don't we put that in something i've been looking at all day. let's put in union pacific. that has come down far below where it should. a nice change for added transport. i think it will be a nice mix. i cannot believe we are done. we have such unbelievable portfolios. it makes you feel so great. thank you to everybody for saying it is a great thing. we've been doing it since 2001. >>> coming up, hit us with your best shot. and electrifying lightning round is next. at morgan stanley, old school hard work meets bold new thinking. to help you see untapped possibilities and relentlessly work with you to make them real. [♪♪] your skin

today >> they found lilly watkins, teenage girl who went missing 13 years ago. >> she put up a fight. >> let's finish it for her. >> i'm missing something. >> she was here. come on. >> it will really happen. her new will trend tonight on abc. >> back now to the rocket that was supposed to push boeing's starliner capsule toward the international space station. now they're still on the ground at cape canaveral, florida, after boeing scrubbed the launch just two hours before it was supposed to happen last night, there was apparently a problem with an oxygen valve. that was the blame there. the earliest possible next launch attempt could be tonight. >> harvey weinstein is back behind bars more than a week after being taken to new york city hospital, the former movie producer is being held at rikers island as he awaits a retrial in his rape case. a spokesperson says correction officials are monitoring weinstein's health. he was taken to the hospital two days after new york's highest court overturned his 2020 conviction. prosecutors hope to retry him in september. >> last september, noelia

far below the list prices of fda approved drugs currently offered by lilly and ovo however does the newze up against existing competition? let's ask the senior vice president of weight management, dr. craig pre-mack doctor, great to have you with us thank you for joining us >> thank you >> the price, obviously, is much, much lower what do you tell patients, though, about safety, particularly when the fda has issued warnings about the safety of compounded semaglutide? >> we spent a lot of time at hims and hers trying to find a pharmacy that could give us both quality, and, so, the pharmacy was very vetted. they went over 400 observations. it is a 403-b compounding facility, which is inspected by the fda. and we had to find not only quality, but affordability, and supply >> sure. there's 403-a and 403-b. 40 403-b, fda licensed, insecond. i would assume they are making a compounded version, and the fda, in its warning in january, has said that it has no basis -- the fda is not aware of any basis of compounding using sodium that would meet federal requirements. do you tell patients that thi

they're rivals to eli lilly and -- lauren: weight loss drugs. they've got one.one of them. it's their weight loss pill. thought that would be so easy, right in take a pill -- stuart: yeah, a winner. lauren: are the trial data wasn't so good, so now they're doubling down on their weight loss shot. it's taken once a month, so less frequently, and it helps keep the weight off -- stuart: you've got that look on your face, bahnsen. >> we're huge shareholders of amgen. i don't think they've scrapped the weight loss bill -- pill, i think they're focus on the injection side. but there's not going to be an a duopoly here. eli lilly down quite a bit today, they've had the full run are on these weight loss pills. again, amgen still has to go to stage three, but they're moving forward to these clinical stus. stuart: the other two can't keep up with the demand -- lauren: supply can't keep up. stuart: amgen, they've got something going for them, who knows when, they can add to the supply. >> also a very promising on cog treatment as well, lungens cancer, is a really, really w

ver que un 20% obtiene estas medicinas en un centro medico estetico o por por los laboratorios eli lillydisk reconocen que la fda tiene actualmente algunos de sus productos en la lista de escasez de medicamentos como disponibilidad limitada lo qu ha llevado a muchos a intentar conseguirlo sin supervision medica. >> esto ocho esto en ocho millones de personas han podido apreciar en varios paises del mundo lo que en ingles ingles se conoce como northern lights o en espanol moradas y hasta verdes que aparecen en el firmamento son producto de una perturbacion en el campo electromagnetico de la tierra debido a una tormenta geomagnetica severa por un aumento en la actividad solar. >> de hecho, los meteorologos espaciales de la noa emitieron una alerta de tormenta geomagnetica severa, la primera en casi 20 anos, advirtiendo al publico sobre los posibles efectos aqui en la tierra, como por ejemplo la afectacion de la red electrica, las comunicaciones por satelite y por radio de alta frecuencia, como son tambien los telefono celulares. >> y precisamente presidente joseph martinez, meteorologo de

just minutes ago, eli lilly announced it's investing an additional $5.3 billion for its manufacturinge in indiana. that brings the company's total pledge to $9 billion. eli lilly says the new investment shows its commitment to meeting demands of megano and zeop, and both are used to treat type two diabetes and obesity. the company embarked on a manufacture expansion in 2020, driven by the research results for those drugs. and we know this has a big impact on a lot of you. a recent survey found that 1 in 8 american adults has taken a weight loss drug like those mentioned, and the demand has led to shortages. back to you. >> thanks, amanda. mechanical issue being blamed for diverting a united airlines flight headed to san francisco to denver yesterday morning. united didn't explain what the issue was, but says the flight from boston landed safely. 175 passengers and crew were able to get off the boeing 737 max nine and switch to another plane to continue the trip. you may remember the faa grounded boeing 737 max nine earlier this year after a door plug detached from an alaska airlines p

eli lilly has great products a great name in the defensive health care space. >> like nvidia, but therethink it is overbought but you think there is more room to run? >> certainly more room to run. your prior guest talked about a.i. proliferation that can't be understated. hard to say things about nvidia that hasn't already been said. there might be improved supply chain to help get the chips out to market further. they take up in a stack necessarily in the data warehouses these days about 80% of compute space. that is only 15% just a mere five years ago. n sid -- nvidia has room to run because of that. they're in ongoing transition. data was a depository of files. people needed extra space to store extra files. now we're talking about serious computer power all things a.i., deep learning, data intensive computing tasks. a lot nvidia can offer. we like the name. we would stick with it. it is cash flow positive clearly and we have earnings report national about a week. ashley: we have another report tomorrow cpi, what are you expecting? if it comes in hotter than expected do we take a le

behavior. media platform watching substation the first podcasts we watch in ireland a domestic goat named lillyy specialize mainly in lost sheep, they often stray from the herd, and so try to go either into the thicket of the forest or into impassable... recently, a lamb got lost along a busy highway, the goat is very quickly found her bearings and, just as well as a dog, led the rescuers to the confused animal. it is interesting that the lost ones never try to run away if they see a lily, they do not feel danger in it, however, the goat really has a very kind disposition. but to the garden it's better not to let in. in sochi, on one of the farms , 10,000 bushes of fragrant damask rose were grown. now it’s time to collect the buds for... what the correspondents will tell you, but now you can see that the rose is completely assembled, but literally in a couple of hours, 2-3 hours, all these buds will open. daria darvina, a farm employee, is ready to talk for hours about the amazing properties of the damask rose, the shrub is unpretentious, can withstand frost in winter, and easily tolerates heat

novo nordisk and lilly should benefit. every time novo nordisk does good buy lilly.ame formula situation. >> doesn't the advent of ai on productivity and advent of these on public health make you optimistic about the future? >> that's why i say it's 18 months and two years. i need jay for time. look guys, the cavalry is coming. it's not -- i mean, i think we're in a fort, not like custard. that last stand he made, suboptimal. >> how about tonight? >> i have stanley black and decker a company that has a division that's 100 years old that is killing it. that's for the professional. we'll hear what they have to say, and i have to tell you, that's a gross margin story, not a sales story, but -- because they don't have the big sales because look at home depot and lowe's and the independents. there's not enough, but they get the gross margins up to 30 and 35, that stock will keep going higher. >> i love you, david. >> i love you too, jim. keep being you. don't worry about the memers. >> during the break i expressed i want to be more valuable to people and feel like if this

in ireland, a domestic goat named lilly is leading the search for missing farm animals.stray from the herd, and so try to go either into the thicket of the forest or into an impassable swamp. well, the lamb got lost along a busy highway, the goat very quickly found its bearings and, just as well as the dog, led the rescuers to the confused animal. interestingly, the lost ones never try to escape if see lily. they do not feel danger in her, however, the decrees are really very kind . but it’s better not to let him into the garden. in sochi , 10,000 bushes of fragrant damask rose were grown on one of the farms. now it's time to collect the buds, for what? he'll tell you. the plantation is brought by 40-50 volunteers who want to take unique shots on the harvest days , but the farm staff limited the number of visitors so as not to harm the plantings, there is not so much growing, even in the garden at the dacha we have this variety, well, there are literally a couple of bushes , well, here we need collect 120 kg by 12 o'clock. i don’t know whether we will make it in time or

she is the first-known jewish appointee to publicly do so in lilly. thank you so much for being with us today first before i talk to you about your decision, here we have this news about the bodies of these three hostages been found. what is your reaction as we've learned this yeah, i mean, i'm i'm devastated and i'm horrified and i'm, you know, it's tragic that they won't be reunited with their families but they. >> won't be able to sit at shabat tables that have been missing them for months. but i think it's very clear that the only way to bring back living hostages is a ceasefire deal. and that's what families of the hostages have been asking for, for months. >> tell us slowly about your decision. how long had you been thinking about this and how did you come to this it's it's been a very challenging personal decision because of my community, because of how i was raised. >> i think from the beginning, i've been very disappointed with the administration and how the rhetoric coming from the president and especially actually around jewish safety and h

pfizer's announcement comes after another drug maker, eli lilly, launched a similar platform back injanuary. the new services come while drug makers are pushing to sell their products directly to consumers, rather than going through a pharmacy. there's a wave of disappointment and frustration for swimmers at acalanes high school tonight. they've learned they won't be able to swim in a critical swimming and diving championship this week. it appears their entries didn't get in in time, and a computer issue may be to blame, nbc bay area's christie smith explains. we're obviously feeling pretty bummed. kyle hansen sums up how some of the swimmers at acalanes high school are feeling with an important meet coming up that their team won't be able to compete in since it's out of our control and out of our reach and we're being penalized for it, so it's pretty devastating, especially since we had our freshman season taken away due due to covid. it's pretty bummed out for our senior season, taken away due to this too. this is like our biggest meet besides state championships in the whole entir

nicolás lilly, de innova, señala que están conscientes de que las personas tienen muchas prioridades.nes es la creencia de que es un proceso complicado y doloroso. yes, there may be some fear associated. lily dice que aunque hay temor, hay que tener en cuenta que el proceso es sencillo toma una hora y el pinchón no se compara con lo que pueden estar pasando aquellas personas en necesidad de sangre para donar. en los estados unidos, las personas deben cumplir con ciertos requisitos como tener al menos 17 años de edad, gozar de buena salud en general y pesar al menos 100 10 £. expertos resaltan que donar sangre es un acto de generosidad que trasciende las barreras culturales. la sangre, dicen, no distingue entre etnias y es un regalo de esperanza a cualquier persona necesitada, no importando a qué comunidad pertenece. nos vamos a nuestra última pausa, pero antes te recuerdo que puedes seguirnos en los medios sociales. facebook e instagram, en las direcciones que ve en su pantalla. además las aplicaciones de telemundo 48, telemundo 33 y telemundo fresno ya están disponibles para iphone,

nicolás lilly, de innova señala que están conscientes que las personas tienen muchas prioridades. comunes es la creencia de que es un proceso complicado y doloroso . yes, there may be some fear associated. lily dice que aunque hay temor, hay que tener en cuenta que el proceso es sencillo. toma una hora y el pinchón no se compara con lo que pueden estar pasando aquellas personas en necesidad de sangre para donar. en los estados unidos, las personas deben cumplir con ciertos requisitos, como tener al menos 17 años de edad, gozar de buena salud en general y pesar al menos 100 10 £ al regresar de la pausa, dan a conocer la identidad del joven que perdió la vida en un accidente en fremont, luego de que el vehículo se prendiera en llamas. y ha pasado ya 4 años desde la pandemia y los estragos en el centro de san josé, aún se sienten con decenas de locales vacíos. entérese cuál es el plan para reactivar la zona. millones de dólares de contribuyentes en california están por irse a las manos de los legisladores. le explde qué otorgó a las familias de california. llegarán a manos no de los

and her name is lilly. as an assistant chief of staff in the department of interior, she was appointed by the present himself president button, which is quitting because of the ridiculous comments that she says the president has made about jude's. geez, jewish yourself. by the way, this is the comment that she is talking about the bothers or folks, or were there? no, israel wouldn't be a jew, the world or safe were there? no, israel, there'd be no jew in the world that is safe. here's what she says. read with me, here's what greenberg call is saying about biden's comment that made her angry as a jewish american quote. he is making jews the face of the american war machine. and that is so deeply wrong, because so many of our ancestors were killed by state sponsored violence. you know, she seems manila to be saying 2 things here. she seems to be saying one that what is real is doing is not making to say for it's making being joyce in the world more dangerous. and so she seems to be comparing our foreign polic

. >> they found lilly watkins teenage girl who went missing 13 years ago. >> she put up a fight.let's finish it for her. i'm missing something. >> she was here. come on. >> it will really happen. her new world trend tuesday on abc >> two. three. i'm only here for life's too short to have a good time. >> so go make your move. make it happen. time fly, start a fi cause it's really high. it's going down tonight >> this season, our new nate and jeremiah collection for living spaces is an updated, well-traveled take on coastal living inspired by some of our favorite coastlines from california to montauk to portugal. >> the clean, modern lines and natural materials, including oak and marble, evoke a sense of calm sophistication designed to mix and match easily with the pieces you already own. >> the collection adds style along with functionality and comfort. >> elevate your home with our new voyage collection from nate and jeremiah only at living spaces. you make me feel dancing. >> join the millions who are feeling the power of osteo bi-flex the number one pharmacist recommended joint

{lilli families of the victims. our hearts go — families of the victims. our hearts go out _

pero al otro lado de la esquina, lilly protect our employees in our customers.acusada de robar 60.000 $ de la tienda target en stumptown. andrés brender noticiero telemundo 48. vamos a retomar el ámbito local para comentarle que pese a la afluencia de personas y el colorido desfile, algunos comerciantes del este de san josé no quedaron tan satisfechos con las celebraciones del 5 de mayo y nos referimos especialmente a quienes operan en el estacionamiento de la tropicana, donde culminó la marcha y quienes en lugar de obtener más ganancias, según nos dijeron, se vieron obligados a cerrar antes de lo previsto. además, señalan que el lugar que debía ser para clientes terminó siendo utilizados por terceros fue desastrosa, ya que tuvimos que cerrar temprano debido a varios desórdenes por parte de gente intoxicada y violenta. venían y estacionaban aquí y se iban para allá. los comerciantes, sin embargo, reconocieron que hubo considerable presencia de la policía de hecho, este departamento informó que este martes se esperan dar a conocer los resultados de los operativos

eli lilly shares getting a 52-week high after the drug maker in with a boston-based startup to deliverp 2.8%. commerzbank getting highs earlier after morgan stanley raised its target to 20 euros. stay tuned to that one. we have burberry hitting a 52 week low after barclays lowered its price target on the stock, remaining cautious in the short-term. shares have fallen over 10% since it reported earnings last week with a week forecast. you can see shares down about 3.8% over the last two days. coming up on bloomberg technology, the cfo of zoom joins caroline hyde. that does it for bloomberg markets. i'm katie greifeld and this is bloomberg. ♪ what about zocdoc? so many options. yeah, and dr. xichun even takes your sketchy insurance. xi-chun, xi-chun, xi-chun! you've got more options than you know. book now. >> this is bloomberg technology with caroline hyde and ed ludlow. ♪ caroline: i am caroline hyde in new york. ed ludlow is off. coming up, baseless of reportingtsmc and asml down the keyq